News for Agent

Daily business news: funding, M&A, launches

Legal & Disputes

Levi & Korsinsky Files FMC Class Action, Sets January 19 Lead Plaintiff Deadline

By ·

Key takeaways

  • Levi & Korsinsky filed Godeas v. FMC Corporation in the Eastern District of Pennsylvania for investors who bought FMC stock between February 4, 2026 and October 14, 2026.
  • FMC shares fell from $8.09 on October 14, 2026 to $5.62 on October 15, 2026, a decline of about 31%.
  • Shareholders have until January 19, 2027 to request appointment as lead plaintiff.

Levi & Korsinsky, LLP has filed a class action against FMC Corporation on behalf of investors who acquired FMC common stock between February 4, 2026 and October 14, 2026, with a lead plaintiff deadline of January 19, 2027. The firm announced the case in a GlobeNewswire release on November 19, 2026.

Inside the Godeas Complaint Against FMC

The case, Godeas v. FMC Corporation, et al. (Case No. 2:26-cv-08831), was commenced in the United States District Court for the Eastern District of Pennsylvania. According to the complaint, FMC gave investors overwhelmingly positive statements while disseminating materially false and misleading statements or concealing material facts about its distributor-inventory problem. The complaint points to the difficulty distributors faced selling elevated-priced inventory, which impaired replenishment orders across FMC's portfolio and threatened the company's ability to generate new sales, revenue, EBITDA and cash flow.

FMC announced preliminary third quarter 2026 results materially below expectations on October 14, 2026, and sharply reduced its revenue and adjusted EBITDA for the quarter. FMC's closing market price was $8.09 per share on October 14, 2026, and fell to $5.62 per share on October 15, 2026, a decline of about 31%.

"Our firm is committed to ensuring that investors receive full compensation for losses caused by corporate misrepresentations," said Joseph E. Levi, a partner at Levi & Korsinsky. "We encourage FMC shareholders to step forward before the January 19, 2027 deadline so we can pursue justice on their behalf."

Levi & Korsinsky is a U.S. plaintiffs' securities litigation law firm that represents institutional and individual investors in securities class actions, derivative suits and M&A litigation on a contingency-fee basis. The firm also issued a shareholder alert on a securities class action against Qfin Holdings, Inc., according to The future of trading.

Levi & Korsinsky's Case Volume

According to akta.pro company records, Levi & Korsinsky reports more than $486.7 million in total settlement funds currently available across active cases and settlements. The same records state the firm has recovered billions for defrauded investors since its founding in 2003, and that its attorneys are admitted in more than 40 state, federal and appeal courts.

Levi & Korsinsky's Recent Filings

Levi & Korsinsky announced an investigation into Grid Dynamics Holdings, Inc. concerning possible breaches of fiduciary duties by certain officers and directors, PR Newswire reported in November 2026. The firm also notified stockholders of an investigation into the fairness of Surgery Partners' acquisition by HealthSpan Partners, which offers $23.50 per share in cash, PR Newswire reported in November 2026. In the same month, PR Newswire reported that Levi & Korsinsky notified stockholders of an investigation into the fairness of The Baldwin Insurance Group's acquisition by Sequence Holdings and DFO Management, which offers $32.50 per share in cash.

FMC's Lead Plaintiff Deadline

Investors who suffered a loss in FMC common stock have until January 19, 2027 to request that the Court appoint them as lead plaintiff. Sharing in any recovery does not require serving as lead plaintiff.

Companies in this story

Sources

Machine-readable: Markdown · JSON